Improving Outcomes in Non-Small Cell Lung Cancer

Recent advances in the treatment of non-small cell lung cancer have completely changed the therapy landscape. This education center is intended to update clinicians treating patients with NSCLC on the latest breaking research, guideline updates, and therapeutic breakthroughs related to lung cancer.
Report Outlines Progress in Lung Cancer Research, Urges More Screening, Prevention Measures

Report Outlines Progress in Lung Cancer Research, Urges More Screening, Prevention Measures

Lung cancer may still be the leading cause of cancer death among American women and men, but more people than ever are surviving the disease...
MRTX849 Shows Clinical Response for NSCLC Patients with KRAS G12C Mutation

MRTX849 Shows Clinical Response for NSCLC Patients with KRAS G12C Mutation

Patients with non-small-cell lung cancer and KRAS G12C mutations demonstrated an objective response after taking MRTX849, an investigational KRAS G12C inhibitor ...
High Fiber Intake, Yogurt Consumption Linked to Risk of Lung Cancer

High Fiber Intake, Yogurt Consumption Linked to Risk of Lung Cancer

Adults who consumed a diet high in fiber and yogurt had a lower risk of developing lung cancer...
Top 5 NSCLC Stories From November

Top 5 NSCLC Stories From November

Research in non-small cell lung cancer seems to be moving at breakneck pace, bringing with it new clinical data that could drastically change the standard of care....
Lorlatinib Demonstrates Clinical Activity in ROS1-Positive NSCLC

Lorlatinib Demonstrates Clinical Activity in ROS1-Positive NSCLC

There may be a new therapeutic option in patients with ROS1-positive non small-cell lung cancer (NSCLC), according to interim findings from an ongoing phase 1-2 study...

Loading...

© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information